Vasoconstrictive and antibacterial combination treatment for rosacea
AssigneeMigreos Human Health B.V.
InventorsMark Leonard Offerhaus, Bjorn Lars Herpers
Life of this patent
Estimating the term…
Abstract
The invention relates to the field of medicine, specifically to the field of treatment of rosacea. The invention relates to a novel composition and a novel kit of parts, both comprising a vasoconstrictive compound and a compound specifically targeting a bacterial cell, preferably a gram positive bacterial cell. The invention further relates to said composition and/or kit of parts for medical use, preferably for treating an individual suffering from rosacea.
Claims8
A method for treating rosacea in a patient in need thereof comprising the sequential or simultaneous administration of a first compound and a second compound to the patient,
- wherein said first compound is a vasoconstrictive compound selected from the group consisting of alpha(1)- and alpha(2)-adrenergic agonists and said second compound is a compound specifically targeting a Staphylococcus cell, and comprises one or more enzymatic active domains exhibiting peptidoglycan hydrolase activity.
Dependencies are inferred from the claim text.